Literature DB >> 11448140

Decreased p38 MAPK activity in end-stage failing human myocardium: p38 MAPK alpha is the predominant isoform expressed in human heart.

L E Lemke1, L J Bloem, R Fouts, M Esterman, G Sandusky, C J Vlahos.   

Abstract

Short duration exposure to cellular stresses have been shown to activate p38 mitogen-activated protein kinase (MAPK) in cultured rat ventricular cardiomyocytes and isolated perfused hearts; however, effects of chronic stress on p38 MAPK are not well understood. This study determined whether alterations in the p38 MAPK pathway occurred prior to end-stage human heart failure. The p38 MAPK alpha isoform was detectable in human cardiac tissue. However, carefully controlled analysis of protein and message in this study demonstrated an absence of the p38 MAPK beta -isoform. Low levels of message for the non-SB203580 sensitive p38 MAPK gamma and delta isoforms were also detected in both normal and failing human myocardium. Ischemic and idiopathic end-stage failing human hearts were compared to non-failing hearts for both p38 alpha MAPK protein level and total p38 MAPK activity. Western blotting techniques demonstrated no significant changes in total p38 alpha MAPK content. However, approximately 75% decreases in active/phosphorylated p38 MAPK (P<0.005) were observed in both ischemic and idiopathic failing hearts compared to non-failing hearts. In-gel kinase assays confirmed that activated p38 MAPK, detected by Western blotting, phosphorylated its potential downstream targets. When compared to non-failing hearts, approximately 46% decreases in p38 MAPK phosphorylation of mitogen-activated protein kinase-activated protein kinase-2 (MAPKAPK-2) were observed in ischemic and idiopathic failing hearts (P=0.03 and P=0.04 respectively). Active p38 MAPK was localized to sarcomeric structures in the cytosol of myocytes by confocal immunofluorescence microscopy. The correlation between decreased MAPKAPK-2 phosphorylation and loss of active p38 MAPK in failing human myocytes suggests that decreases in the activation of p38 MAPK alpha, the predominant cardiac isoform, occur prior to end-stage heart failure. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11448140     DOI: 10.1006/jmcc.2001.1415

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  21 in total

1.  Bax translocates to mitochondria of heart cells during simulated ischaemia: involvement of AMP-activated and p38 mitogen-activated protein kinases.

Authors:  Michela Capano; Martin Crompton
Journal:  Biochem J       Date:  2006-04-01       Impact factor: 3.857

2.  Impaired p38 MAPK/HSP27 signaling underlies aging-related failure in opioid-mediated cardioprotection.

Authors:  Jason N Peart; Eric R Gross; John P Headrick; Garretta J Gross
Journal:  J Mol Cell Cardiol       Date:  2007-02-28       Impact factor: 5.000

3.  Overexpression of mitogen-activated protein kinase kinase 6 in the heart improves functional recovery from ischemia in vitro and protects against myocardial infarction in vivo.

Authors:  Joshua J Martindale; Jason A Wall; Diana M Martinez-Longoria; Prafulla Aryal; Howard A Rockman; Yiru Guo; Roberto Bolli; Christopher C Glembotski
Journal:  J Biol Chem       Date:  2004-10-18       Impact factor: 5.157

4.  Phosphoprotein abundance changes in hypertensive cardiac remodeling.

Authors:  Kumar Kotlo; Keven R Johnson; Jean M Grillon; David L Geenen; Pieter deTombe; Robert S Danziger
Journal:  J Proteomics       Date:  2012-05-31       Impact factor: 4.044

Review 5.  The p38 mitogen-activated protein kinase pathway--a potential target for intervention in infarction, hypertrophy, and heart failure.

Authors:  Michael S Marber; Beth Rose; Yibin Wang
Journal:  J Mol Cell Cardiol       Date:  2010-11-06       Impact factor: 5.000

Review 6.  Mitogen-activated protein kinases: a new therapeutic target in cardiac pathology.

Authors:  Tána Ravingerová; Miroslav Barancík; Monika Strnisková
Journal:  Mol Cell Biochem       Date:  2003-05       Impact factor: 3.396

7.  Targeted inhibition of p38 MAPK promotes hypertrophic cardiomyopathy through upregulation of calcineurin-NFAT signaling.

Authors:  Julian C Braz; Orlando F Bueno; Qiangrong Liang; Benjamin J Wilkins; Yan-Shan Dai; Stephanie Parsons; Joseph Braunwart; Betty J Glascock; Raisa Klevitsky; Thomas F Kimball; Timothy E Hewett; Jeffery D Molkentin
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

8.  Low-dose radiation affects cardiac physiology: gene networks and molecular signaling in cardiomyocytes.

Authors:  Matthew A Coleman; Sharath P Sasi; Jillian Onufrak; Mohan Natarajan; Krishnan Manickam; John Schwab; Sujatha Muralidharan; Leif E Peterson; Yuriy O Alekseyev; Xinhua Yan; David A Goukassian
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-09-25       Impact factor: 4.733

Review 9.  Regulation of Ncx1 gene expression in the normal and hypertrophic heart.

Authors:  Donald R Menick; Ludivine Renaud; Avery Buchholz; Joachim G Müller; Hongming Zhou; Christiana S Kappler; Steven W Kubalak; Simon J Conway; Lin Xu
Journal:  Ann N Y Acad Sci       Date:  2007-03       Impact factor: 5.691

10.  Reciprocal regulation of beta-adrenergic receptor mRNA stability by mitogen activated protein kinase activation and inhibition.

Authors:  Violetta V Headley; Rasheeda Tanveer; Scott M Greene; Adam Zweifach; J David Port
Journal:  Mol Cell Biochem       Date:  2004-03       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.